S100P and pachyonychia congenita: To validate the expression and clinical significance of S100P and CTSE in PC, we analyzed tissue microarrays (TMAs) containing samples from 90 patients with PC and paired adjacent non-cancerous tissues, performing immunohistochemistry (IHC) to assess the expression levels of these proteins.